Regeneron's Ebola treatment proves superior to rival in trial

Regeneron's Ebola treatment proves superior to rival in trial

Source: 
Yahoo/Reuters
snippet: 

Regeneron Pharmaceuticals Inc said on Monday its experimental treatment for Ebola proved superior to a rival therapy from Mapp Biopharmaceutical at preventing death, in a trial evaluating four treatments for infections caused by the deadly virus.